Literature DB >> 15186609

Differences in thyroid-infiltrating B lymphocytes in patients with Graves' disease: relationship to autoantibody detection.

Carmen Segundo1, Carmen Rodríguez, Manuel Aguilar, Antonio García-Poley, Inmaculada Gavilán, Carmen Bellas, José A Brieva.   

Abstract

OBJECTIVE: Thyroid-infiltrating B (Thyr-B) lymphocytes are thought to play an important role in the pathogenic mechanisms underlying Graves' disease. DESIGN AND METHODS: In this study, a broad phenotypic analysis of these cells has been performed in 15 consecutive patients who underwent thyroidectomy.
RESULTS: Data reveal the occurrence of two distinct types of Thyr-B cell infiltrates. Type 1 was present in most of the cases (10/15) and consisted of a combination of IgM+ IgD(low to-) B lymphocytes showing features of marginal zone B cells, and IgG+ classic memory B cells. In contrast, in 5 of the 15 cases, a second type of Thyr-B cell infiltrate occurred, exhibiting the profile IgM- IgD- CD44(low to-) CD38++ CD71+ CD95+. This phenotype is highly suggestive of germinal center (GC) B cells, a finding not always anticipated from routine histologic examination. The presence of these ectopic GC was closely associated with the elevated serum level of anti-thyroid peroxidase (TPO), but not with anti-thyrotropin receptor (TSHR), autoantibodies. Moreover, local active anti-thyroglobulin (Tg) antibody secretion was only detected in cultures of type 2 Thyr-B cells.
CONCLUSION: These findings indicate that high titers of anti-TPO, but not anti-TSHR antibody, might be associated with intrathyroidal GC development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15186609     DOI: 10.1089/105072504774193159

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

Review 1.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

2.  Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease.

Authors:  Ben-Skowronek Iwona; Sierocinska-Sawa Jadwiga; Korobowicz Elzbieta; Szewczyk Leszek
Journal:  World J Pediatr       Date:  2008-12-23       Impact factor: 2.764

3.  Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.

Authors:  Mia J Smith; Marynette Rihanek; Brianne M Coleman; Peter A Gottlieb; Virginia D Sarapura; John C Cambier
Journal:  J Autoimmun       Date:  2017-12-09       Impact factor: 7.094

4.  The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.

Authors:  K Van der Weerd; P M Van Hagen; B Schrijver; D J Kwekkeboom; W W De Herder; M R J Ten Broek; P T E Postema; J J M Van Dongen; F J T Staal; W A Dik
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

5.  Distribution of lymphocyte subpopulations in thyroid glands of human autoimmune thyroid disease.

Authors:  Bingbing Zha; Xiuyan Huang; Jun Lin; Jun Liu; Yingyong Hou; Guilong Wu
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

Review 6.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

7.  Peripheral immunophenotyping of AITD subjects reveals alterations in immune cells in pediatric vs adult-onset AITD.

Authors:  Zachary C Stensland; Brianne M Coleman; Marynette Rihanek; Ryan M Baxter; Peter A Gottlieb; Elena W Y Hsieh; Virginia D Sarapura; Kimber M Simmons; John C Cambier; Mia J Smith
Journal:  iScience       Date:  2021-12-13

8.  Hematological Indexes Can Be Used to Predict the Incidence of Hypothyroidism in Nasopharyngeal Carcinoma Patients after Radiotherapy.

Authors:  Ling Zhou; Jia Chen; Chang-Juan Tao; Shuang Huang; Jiang Zhang; Wei Shen; Chao-Nan Zhu; Ming Chen; Zhong-Hua Yu; Yuan-Yuan Chen
Journal:  Biomed Res Int       Date:  2020-05-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.